ArticleOncoTargets and therapy2016

miR-125b inhibited epithelial-mesenchymal transition of triple-negative breast cancer by targeting MAP2K7.

Liquan Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.